FM
PBYI icon

Forward Management’s Puma Biotechnology PBYI Stock Holding History

Forward Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,825
Closed -$980K – 404
2014
Q2 		$980K Buy
16,825
+5,954
+55% +$423K 0.06% 152
2014
Q1 		$515K Sell
10,871
-3,032
-22% -$356K 0.03% 222
2013
Q4 		$721K Sell
13,903
-3,335
-19% -$196K 0.04% 179
2013
Q3 		$617K Buy
17,238
+2,540
+17% +$137K 0.04% 193
2013
Q2 		$363K Buy
+14,698
New +$518K 0.03% 264

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Forward Management's PBYI Position: Q3 2014 in Review

Forward Management sold out of Puma Biotechnology (PBYI) in Q3 2014, closing a stake of 16,825 shares — an estimated $980K sold.

Forward Management first reported a position in PBYI in Q2 2013 and held it in 5 quarters. The position peaked at $980K in Q2 2014. 184 funds tracked by Wall St. Rank hold PBYI as of Q3 2014.

  • Forward Management reported no remaining Puma Biotechnology position as of Q3 2014 after selling out during the quarter.
  • Forward Management sold 16,825 Puma Biotechnology shares in Q3 2014, an estimated $980K.
  • Forward Management first reported a position in Puma Biotechnology in Q2 2013 and held it in 5 quarters.
  • Forward Management's Puma Biotechnology position peaked at $980K in Q2 2014.
  • 184 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2014.

Based on Forward Management's 13F filing for Q3 2014, filed 12 Nov 2014.